New MRI contrast agent tested on big animals

(Institute for Basic Science) Experiments in dogs, rabbits and monkeys show the efficacy and biocompatibility of a new MRI/MRA contrast agent in detecting stroke. This T1 MRI contrast agent based on ultrasmall iron oxide nanoparticles could become a possible alternative to clinically used gadolinium-based agents.

https://www.eurekalert.org/pub_releases/2017-07/ifbs-nmc073017.php

Source: EurekAlert! - Cancer - July 31, 2017 Category: Cancer & Oncology Source Type: news